Obstructive nephropathy and renal fibrosis

American Journal of Physiology - Renal Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Klahr, Saulo ^a   Morrissey, Jeremiah ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Apoptosis; Gene knockout models; Renal fibrosis; Tubular atrophy

Indexed keywords

AMINONUCLEOSIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ATROPHY; DISEASE COURSE; ENZYME INHIBITION; HEYMANN NEPHRITIS; HUMAN; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TUBULE; KNOCKOUT MOUSE; MOUSE; NEPHROTIC SYNDROME; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REVIEW; RODENT; URETER OBSTRUCTION;

EID: 0036839599     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00362.2001     Document Type: Review

References (103)

1. Albertazzi E, Cajone F, and Sherbet GV. Characterization of a splice variant of metastasis-associated h-mts1 (S100A4) gene expressed in human infiltrating carcinomas of the breast. DNA Cell Bio 17: 1003-1008, 1998.
2. Brasier AR and Li J. Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27: 465-475, 1996.
3. Brasier AR, Li J, and Wimbish KA. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A. transactivator. Hypertension 27: 1009-1017, 1996.
4. Chevalier RL. Growth factors and apoptosis in neonatal ureteral obstruction. J Am Soc Nephrol 7: 1098-1105, 1996.
5. Chevalier RL. Pathophysiology of obstructive nephropathy in the newborn. Semin Nephrol 18: 585-593, 1998.
6. Chevalier RL, Goyal S, Kim A, Chang AY, Landau D, and LeRoith D. Renal tubulointerstitial injury from ureteral obstruction in the neonatal rat is attenuated by IGF-1. Kidney Int 57: 882-890, 2000.
7. Chevalier RL, Goyal S, Wolstenholme JT, and Thornhill BA. Obstructive nephropathy in the neonate is attenuated by epidermal growth factor. Kidney Int 54: 38-47, 1998.
8. Chevalier RL, Smith CD, Wolstenholme JT, Krajewski S, and Reed JC. Chronic ureteral obstruction in the rat suppresses renal tubular bcl-2 and stimulates apoptosis. Exp Nephrol 8: 115-122, 1999.
9. Chevalier RL, Thornhill BA, and Wolstenholme JT. Renal cellular response to ureteral obstruction: Role of maturation and angiotensin II. Am J Physiol Renal Physiol 277: F41-F47, 1999.
10. Chevalier RL, Thornhill BA, Wolstenholme JT, and Kim A. Unilateral ureteral obstruction in early development alters renal growth: Dependence on the duration of obstruction. J Urol 161: 309-313, 1999.
11. Choi YJ, Mendoza L, Rha SJ, Sheikh-Hamad D, Baranowska-Daca E, Nguyen V, Smith CW, Nassar G, Suki WN, and Truong LD. Role of p53-dependent activation of caspases in chronic obstructive uropathy: Evidence from p53 null mutant mice. J Am Soc Nephrol 12: 983-992, 2001.
12. Crisman JM, Richards LL, Valach DP, Franzoni DF, and Diamond JR. Chemokine expression in the obstructed kidney. Exp Nephrol 9: 241-248, 2001.
13. Duymelinck C, Dauwe SE, De Greef KE, Ysebaert DK, Verpooten GA, and De Broe ME. TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat. Kidney Int 58: 1186-1201, 2000.
14. Eddy AA. Molecular insights into renal interstitial fibrosis J Am Soc Nephrol 7: 2495-2508, 1996.
15. Feldman DL, Mogelesky TC, Chou M, and Jeng AY. Enhanced expression of renal endothelin-converting enzyme-1 and endothelin-A-receptor mRNA in rats with interstitial fibrosis following ureter ligation. J Cardiovasc Pharmacol 36: S255-S259, 2000.
16. Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, and Chevalier RL. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest 103: 39-46, 1999.
17. 1. mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 281: F513-F521, 2001.
18. KIP1 after unilateral ureteral obstruction is independent of angiotensin II. Kidney Int 61: 68-79, 2002.
19. Gobe G, Fung LCT, and Buttyan R. Hallmark and consequences of apoptosis and necrosis in the kidney. In: Contemporary Issues in Nephrology. Acute Renal Failure, edited by Goligorsky MS and Stein JH. New York: Churchill Livingstone, 1995, vol. 30, p 143-159.
20. Griffith TS, Brunner T, Fletcher SM, Green DR, and Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 70: 1189-1192, 1995.
21. Guijarro C and Egido J. Transcription factor-κB (NF-κB) and renal disease. Kidney Int 59: 415-424, 2001.
22. Guo G, Morrissey J, McCracken R, Tolley T, and Klahr S. The role of TNFR1 and TNFR2 receptors in the interstitial fibrosis of obstructive nephropathy. Am J Physiol Renal Physiol 277: F766-F772, 1999.
23. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, and Klahr S. Contributions of angiotensin II and tumor necrosis factor-α to the development of renal fibrosis. Am J Physiol Renal Physiol 280: F777-F785, 2001.
24. Hay ED and Zuk A. Transformations between epithelium and mesenchyme: Normal, pathological, and experimentally induced. Am J Kidney Dis 26: 678-690, 1995.
25. Hegarty NJ, Young LS, Kirwan CN, O'Neill AJ, Bouchier-Hayes DM, Sweeney P, Watson RW, and Fitzpatrick JM. Nitric oxide in unilateral ureteral obstruction: effect on regional renal blood flow. Kidney Int 59: 1059-1065, 2001.
26. Hochberg D, Johnson CW, Chen J, Cohen D, Stern J, Vaughan ED Jr, Poppas D, and Felsen D. Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest 80: 1721-1728, 2000.
27. Hruska KA, Guo G, Wozniak M, Martin D, Miller S, Liapis H, Loveday K, Klahr S, Sampath TK, and Morrissey J. Osteogenic protein-1 prevents renal fibrogensis associated with ureteral obstruction. Am J Physiol Renal Physiol 279: F130-F143, 2000.
28. CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol Renal Physiol 277: F948-F956, 1999.
29. Isaka Y, Tsujie M, Ando Y, Nakamura H, Kaneda Y, Imai E, and Hori M. Transforming growth factor-beta-1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction. Kidney Int 58: 1885-1892, 2000.
30. Ishidoya S, Morrissey JJ, McCracken R, Reyes A, and Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285-1294, 1995.
31. Iwano M, Fischer A, Okada H, Plieth D, Xue C, Danoff TM, and Neilson EG. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther 3: 149-159, 2001.
32. Kaneto H, Morrissey J, and Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993.
33. Kaneto H, Morrissey J, McCracken R, Ishidoya S, Reyes A, and Klahr S. The expression of mRNA for tumor necrosis factor-α increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology 2: 161-166, 1996.
34. Kaneto H, Ohtani H, Fukuzaki A, Ishidoya S, Takeda A, Ogata Y, Nagura H, and Orikasa S. Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy. Kidney Int 56: 2137-2146, 1999.
35. Kennedy WA II, Buttyan R, Garcia-Montes E, D'Agati V, Olsson CA, and Sawczuk IS. Epidermal growth factor suppresses renal tubular apoptosis following ureteral obstruction. Urology 49: 973-980, 1997.
36. Khan MA, Dashwood MR, Thompson CS, Mumtaz FH, Mikhailidis DP, and Morgan RJ. Time-dependent up-regulation of endothelin-A receptors and down-regulation of endothelin-B receptors and nitric oxide synthase binding sites in the renal medulla of a rabbit model of partial bladder outlet obstruction: Potential clinical relevance. BJU Int 84: 1073-1080, 1999.
37. Kim H, Oda T, Lopez-Guisa J, Wing D, Edwards DR, Soloway PD, and Eddy AA. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 12: 736-748, 2001.
38. Klahr S. Nephrology Forum: Obstructive nephropathy. Kidney Int 54: 286-300, 1998.
39. Klahr S and Morrissey JJ. The role of growth factors, cytokines and vasoactive compounds in obstructive nephropathy. Semin Nephrol 18: 622-632, 1998.
40. Klahr S and Morrissey JJ. Angiotensin II and gene expression in the kidney. Am J Kidney Dis 31: 171-176, 1998.
41. Klahr S and Morrissey JJ. Comparative study of ACE inhibitors and AII receptor antagonists in interstitial scarring. Kidney Int 52, Suppl 63: S111-S114, 1997.
42. Knerr I, Nyul Z, Miller J, Rosch W, Dotsch J, Repp R, Weidner W, and Rascher W. Increased endothelin-1 and decreased adrenomedullin gene expression in the stenotic tissue of congenital pelvi-ureteric junction obstruction in children. BJUInt 87: 667-671, 2001.
43. Kopp JB. Hepatocyte growth factor: Mesenchymal signal for epithelial homeostasis. Kidney Int 54: 1392-1393, 1998.
44. Kumar S. Mechanisms mediating caspase activation in cell death. Cell Death Differ 6: 1060-1066, 1999.
45. Lehtonen JY, Horiuchi M, Daviet L, Akishita M, and Dzau VJ. Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis. J Biol Chem 274: 16901-16906, 1999.
46. Li J and Brazier AR. Angiotensinogen gene activation by angiotensin II is mediated by the Rel A. (nuclear factor-κB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10: 252-264, 1996.
47. Lieberthal W, Koh JS, and Levine JS. Necrosis and apoptosis in acute renal failure. Semin Nephrol 18: 505-518, 1998.
48. Lin KC, Krieg RJ Jr, Saborio P, and Chan JC. Increased heat shock protein-70 in unilateral ureteral obstruction in rats. Mol Genet Metab 65: 303-310, 1998.
49. Malik RK, Thornhill BA, Chang AY, Kiley SC, and Chevalier RL. Apoptosis parallels ceramide content in the developing rat kidney. Pediatr Nephrol 15: 188-191, 2000.
50. Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C, and Egido J. Tubular NF-kappa B and AP-1 activation in human proteinuric renal disease. Kidney Int 60: 1366-1377, 2001.
51. Miller SB, Martin DR, Kissane J, and Hammerman MR. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol Renal Fluid Electrolyte Physiol 266: F129-F134, 1994.
52. Miyajima A, Chen J, Lawrence C, Ledbetter S, Soslow RA, Stern J, Jha S, Pigato J, Lemer ML, Poppas DP, Vaughan ED, and Felsen D. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58: 2301-2313, 2000.
53. Miyajima A, Chen J, Poppas DP, Vaughan ED Jr, and Felsen D. Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 59: 1290-1303, 2001.
54. Mizuno S, Matsumoto K, and Nakamura T. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int 59: 1304-1314, 2001.
55. Morrissey JJ, Guo G, McCracken R, Tolley T, and Klahr S. Induction of CD14 in tubular epithelial cells during kidney disease. J Am Soc Nephrol 11: 1681-1690, 2000.
56. Morrissey JJ, Hruska K, Guo G, Wang S, and Klahr S. Bone morphogenetic protein-7 (BMP-7) improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 3: S14-S21, 2002.
57. Morrissey JJ, Ishidoya S, McCracken R, and Klahr S. The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int 49, Suppl 54: S83-S87, 1996.
58. Morrissey JJ, Ishidoya S, McCracken R, and Klahr S. Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction. Kidney Int 50, Suppl 57: S84-S92, 1996.
59. Morrissey JJ, Ishidoya S, McCracken R, and Klahr S. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7: 2202-2212, 1996.
60. 2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol Renal Physiol 276: F39-F45, 1999.
61. Morrissey JJ and Klahr S. Enalapril decreases nuclear factor KB activation in the kidney with ureteral obstruction. Kidney Int 52: 926-933, 1997.
62. Morrissey JJ and Klahr S. Transcription factor NF-κB regulation of renal fibrosis. Semin Nephrol 18: 603-611, 1998.
63. Morrissey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, and Klahr S. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 45: 998-1005, 1994.
64. Muller DN, Mervaala EM, Schmidt F, Park JK, Dechend R, Genersch E, Breu V, Loffler BM, Ganten D, Schneider W, Haller H, and Luft FC. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced endorgan damage. Hypertension 36: 282-290, 2000.
65. Mulligan MS, Johnson KJ, Todd RF, Issekutz TB, Miyasaka M, Tamatani T, Smith CW, Anderson DC, and Ward PA. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91: 577-587, 1993.
66. Nguyen HT, Bride SH, Badawy AB, Adam RM, Lin J, Orsola A, Guthrie PD, Freeman MR, and Peters CA. Heparin-binding EGF-like growth factor is up-regulated in the obstructed kidney in a cell- and region-specific manner and acts to inhibit apoptosis. Am J Pathol 156: 889-898, 2000.
67. Nguyen HT, Thomson AA, Kogan BA, Baskin LS, and Cunha GR. Expression of the Wnt gene family during late nephrogenesis and complete ureteral obstruction. Lab Invest 79: 647-658, 1999.
68. Oda T, Jung YO, Kim HS, Cai X, Lopez-Guisa JM, Ikeda Y, and Eddy AA. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction. Kidney Int 60: 587-596, 2001.
69. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, and Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
70. Kip1 safeguards against inflammatory injury. Nat Med 4: 575-580, 1998.
71. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, and Johnson RJ. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56: 571-80, 1999.
72. Ortiz A, Bustos C, Alcazar A, Lopez-Armada MJ, Plaza JU, Gonzalez E, and Egido J. Involvement of tumor necrosis factor-α in the pathogenesis of experimental, and human glomerulonephritis. In: Advances in Nephrology, edited by Grunfeld JP, Bach JF, Kreis H, and Maxwell MH. St. Louis, MO: Mosby, 1995, p 53-77.
73. Park KM, Kramers C, Vayssier-Taussat M, Chen A, and Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem.277: 2040-2049, 2002.
74. Poucell-Hatton S, Huang M, Bannykh S, Benirschke K, and Masliah E. Fetal obstructive uropathy: patterns of renal pathology. Pediatr Dev Pathol 3: 223-331, 2000.
75. Prendergast GC. Mechanisms of apoptosis by c-Myc. Oncogene 18: 2967-2987, 1999.
76. Reyes AA and Klahr S. Renal function after release of ureteral obstruction: Role of endothelin, and the renal artery endothelium. Kidney Int 42: 632-638, 1992.
77. Reyes AA, Lefkowith J, Pippin J, and Klahr S. Role of the 5-lipooxygenase pathway in obstructive nephropathy. Kidney Int 41: 100-106, 1992.
78. Reyes AA, Robertson G, and Klahr S. Role of vasopressin in rats with bilateral ureteral obstruction. Proc Soc Exp Biol Med 197: 49-55, 1991.
79. Saba JD, Obeid LM, and Hannun YA. Ceramide: An intracellular mediator of apoptosis and growth suppression. Philos Trans R Soc Lond Biol 351: 233-244, 1996.
80. Satoh M, Kashihara N, Yamasaki Y, Maruyama K, Okamoto K, Maeshima Y, Sugiyama H, Sugaya T, Murakami K, and Makino H. Renal interstitial fibrosis is reduced in angiotensin II type la receptor-deficient mice. J Am Soc Nephrol 12: 317-325, 2001.
81. Schmitz D and Berk BC. Angiotensin II signal transduction stimulation of multiple mitogen activated protein kinase pathways. Trends Endocrinol Metab 8: 261-266, 1997.
82. Serlachius E, Svennilson J, Schalling M, and Aperia A. Protein kinase C in the developing kidney: Isoform expression and effects of ceramide and PKC inhibitors. Kidney Int 52: 901-910, 1997.
83. Shankland SJ. Cell-cycle control and renal disease. Kidney Int 52: 294-308, 1997.
84. Siragy HM, Howell NL, Ragsdale NV, and Carey RM. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 25: 1021-1024, 1995.
85. Stahl PJ and Felsen D. Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: Implications for fibrosis in kidney disease. Am J Pathol 159: 1187-1192, 2001.
86. Stoneking BJ, Hunley TE, Nishimura H, Ma J, Fogo A, Inagami T, Tamura M, Adams MC, Brock JW III, and Kon V. Renal angiotensin converting enzyme promotes renal damage during ureteral obstruction. J Urol 160: 1070-1074, 1998.
87. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, and Neilson EG. Identification, and characterization of a fibroblast marker: F.SP1. J Cell Biol 130: 393-405, 1995.
88. Surendran K, McCaul SP, and Simon TC. A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol 282: F431-F441, 2002.
89. Sweeney P, Young LS, and Fitzpatrick JM. An autoradiographic study of regional blood flow distribution in the rat kidney during ureteric obstruction the role of vasoactive compounds. BJU Int 88: 268-272, 2001.
90. Truong LD, Choi YJ, Tsao CC, Ayala G, Sheikh-Hamad D, Nassar G, and Suki WN. Renal cell apoptosis in chronic obstructive uropathy: The roles of caspases. Kidney Int 60: 924-934, 2001.
91. Truong LD, Petrusevska G, Yang G, Gurmipar T, Shappell S, Lechago J, Rouse D, and Suki WN. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 50: 200-207, 1996.
92. Van Kats JP, Schalekamp MA, Verdouw PD, Duncker DJ, and Danser AH. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 60: 2311-2317, 2001.
93. Vaux DL and Korsmeyer SJ. Cell death in development. Cell 96: 245-254, 1999.
94. Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Grone HJ, and Schlondorff D. Obstructive nephropathy in the mouse: Progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol 12: 1173-1187, 2001.
95. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Bräsen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Böhm M, Meinertz T, and Münzel T. Increased NADH oxidase-mediated super-oxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system. Circulation 99: 2027-2033, 1999.
96. Wendt T, Zhang YM, Bierhaus A, Kriegsmann J, Deng Y, Waldherr R, Teske T, Luther T, Funfstuk R, Nawroth PP, and Stein G. Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10: 1820-1828, 1995.
97. Wolf G, Aberle S, Thaiss F, Nelson PJ, Kaensky AM, Neilson EG, and Strahl RA. TNFα. induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int 44: 795-804, 1993.
98. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, and Kelley VE. Class II MHC antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37: 783-792, 1990.
99. Wyllie AH, Kerr JF, and Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 68: 251-306, 1980.
100. Yamagishi H, Yokoo T, Imasawa T, Mitarai T, Kawamura T, and Utsunomiya Y. Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 166: 609-616, 2001.
101. Yang J and Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13: 96-107, 2002.
102. Yo Y, Morishita R, Yamamoto K, Tomita N, Kida I, Hayashi S, Moriguchi A, Kato S, Matsumoto K, Nakamura T, Higaki J, and Ogihara T. Actions of hepatocyte growth factor as a local modulator in the kidney: Potential role in pathogenesis of renal disease. Kidney Int 53: 50-58, 1998.
103. Yokoo T, Ohashi T, Utsunomiya Y, Shen JS, Hisada Y, Eto Y, Kawamura T, Hosoya Yoo KH T, Thornhill BA, and Chevalier RL. Angiotensin stimulates TGF-β1 and clusterin in the hydronephrotic neonatal rat kidney. Am J Physiol Regul Integr Comp Physiol 278: R640-R642, 2000.